PS Ratio: 41.46

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 41.46 is in line with its estimated 5-year average of 44.29, near the low end of its estimated 5-year range (11.53–142.21).

As of 2026-10-06T16:17:45.498Z. 50.85% below its estimated 12-month average of 84.35.

MIST PS Ratio Metrics

P/S vs. estimated history

At 41.46, P/S is above its estimated 5-year median — higher than 69% of readings in its estimated 5-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Milestone Pharmaceuticals Inc. (MIST)?

The P/S ratio for MIST stock is 41.46.

Is Milestone Pharmaceuticals Inc.'s P/S ratio high or low?

The P/S ratio of 41.46 is in line with its estimated 5-year average of 44.29, near the low end of its estimated 5-year range (11.53–142.21).

What is the estimated TTM average P/S ratio for Milestone Pharmaceuticals Inc. (MIST)?

The estimated TTM average P/S ratio for MIST stock is 84.35.

What is the estimated 3Y average P/S ratio for Milestone Pharmaceuticals Inc. (MIST)?

The estimated 3Y average P/S ratio for MIST stock is 50.99.

What is the estimated 5Y average P/S ratio for Milestone Pharmaceuticals Inc. (MIST)?

The estimated 5Y average P/S ratio for MIST stock is 44.29.

Showing the most recent 260 of 763 data points. The chart above shows the full history.

Related Metrics